Indian Journal of Cancer Home 

ORIGINAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2013  |  Volume : 50  |  Issue : 3  |  Page : 195--199

P-glycoprotein expression as a predictor of response to neoadjuvant chemotherapy in breast cancer

S Vishnukumar1, G Umamaheswaran2, D Anichavezhi2, S Indumathy2, C Adithan2, K Srinivasan1, D Kadambari1 
1 Department of Surgery, Jawaharlal Institute of Postgraduate Medical Education & Research, Pondicherry, India
2 ICMR Centre for Advanced Research in Pharmacogenomics, Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education & Research, Pondicherry, India

Correspondence Address:
S Vishnukumar
Department of Surgery, Jawaharlal Institute of Postgraduate Medical Education & Research, Pondicherry
India

Background: Chemoresistance is an important factor determining the response of tumor to neoadjuvant chemotherapy (NACT). P-glycoprotein (P-gp) expression-mediated drug efflux is one of the mechanisms responsible for multi-drug resistance. Our study was aimed to determine the role of P-gp expression as a predictor of response to NACT in locally advanced breast cancer (LABC) patients. Materials and Methods: P-gp expression was performed by real-time quantitative polymerase chain reaction [qRT-PCR] in 76 patients with LABC. Response to adriamycin-based regimen was assessed both clinically and with contrast enhanced computed tomography (CECT) scan before and after NACT. The significance of correlation between tumor and P-gp levels was determined with Chi-square test. Results: Twenty-one had high and 55 had low P-gp expression. On analyzing P-gp expression with response by World Health Organization (WHO) criteria, statistical significance was obtained (P = 0.038). Similarly, assessment of P-gp expression with response by Response Evaluation in Solid Tumors (RECIST) criteria in 48 patients showed statistical significance (P = 0.0005). Conclusion: This study proves that P-gp expression is a determinant factor in predicting response to NACT. Finally, detection of P-gp expression status before initiation of chemotherapy can be used as a predictive marker for NACT response and will also aid in avoiding the toxic side effects of NACT in non-responders.


How to cite this article:
Vishnukumar S, Umamaheswaran G, Anichavezhi D, Indumathy S, Adithan C, Srinivasan K, Kadambari D. P-glycoprotein expression as a predictor of response to neoadjuvant chemotherapy in breast cancer.Indian J Cancer 2013;50:195-199


How to cite this URL:
Vishnukumar S, Umamaheswaran G, Anichavezhi D, Indumathy S, Adithan C, Srinivasan K, Kadambari D. P-glycoprotein expression as a predictor of response to neoadjuvant chemotherapy in breast cancer. Indian J Cancer [serial online] 2013 [cited 2020 Apr 9 ];50:195-199
Available from: http://www.indianjcancer.com/article.asp?issn=0019-509X;year=2013;volume=50;issue=3;spage=195;epage=199;aulast=Vishnukumar;type=0